Discovery / Disease Prevention
Drug development / Genetics and genomics
Drug development:
What to knowRandomized Clinical Trial (RCT) has long been the standard of conduct for life sciences companies in their efforts to bring new therapies to the marketplace. Given the cost (average ~$2.5B) and time (5-10 years) to complete an RCT, there has been a movement to explore data-driven approaches to drug discovery in recent years. The Pragmatic Clinical Trial (PCT) has gained traction, which is an approach that combines traditional patient/site interactions with analytical-centered constructs that have the goal of accelerating the outcomes of testing without reducing effectiveness.
How we can helpOur AI expertise can provide computer simulations, even before the clinical trial phase, to understand how bench compounds interact with body proteins so that formulation iterations can occur in real-time.
Genetics and Genomics:
What to knowThe advent of advanced research around DNA continues to improve the diagnosis and treatment of various diseases. This research when applied to the individual – referred to as personalized medicine – has the potential to revolutionize the standard of care across many disease states.
How we can helpI3Infotek’s data scientists and AI experts help accelerate deeper understanding of the impact of DNA on health, unlocking the biological connection between genetics, diseases, and drug response - by combining genomic and traditional laboratory data with data science techniques.